A drug is something that affects your body. Drugs must to pass through the body and into the brain.
In pharmacology, a pharmaceutical drugcalled a medication or medicine
It is a chemical substance used to treat, cure, prevent, ordiagnose a disease
My name is Megan Johnson. My presentation is on Drug Addiction. The warning signs, Effects on the brain, and how it is possible to recover from addiction.
Drugs –What they Are and What they Do ?
CONSUMPTION OF VARIOUS DRUGS
Two main Categories of Drugs
Why do so many Teenagers start down this potentially Dangerous path ?
- Why do people start?
Causes
TREATMENT
Think again
Drug Dependence & Abuse - Presentation by Akshay AnandAkshay Anand
A presentation on Drug Dependence and Drug Abuse that explains in brief about the various practices of substance abuse and dependence and the medicinal agents and drugs that can be used to overcome or treat such abuses. This was presented as a part of curriculum by Akshay Anand in Sree Siddaganga College of Pharmacy during May 2013.
My name is Megan Johnson. My presentation is on Drug Addiction. The warning signs, Effects on the brain, and how it is possible to recover from addiction.
Drugs –What they Are and What they Do ?
CONSUMPTION OF VARIOUS DRUGS
Two main Categories of Drugs
Why do so many Teenagers start down this potentially Dangerous path ?
- Why do people start?
Causes
TREATMENT
Think again
Drug Dependence & Abuse - Presentation by Akshay AnandAkshay Anand
A presentation on Drug Dependence and Drug Abuse that explains in brief about the various practices of substance abuse and dependence and the medicinal agents and drugs that can be used to overcome or treat such abuses. This was presented as a part of curriculum by Akshay Anand in Sree Siddaganga College of Pharmacy during May 2013.
drug abuse- what is it? most common stimulants, cocaine abuse, aderall abuse, meth abuse, physiology of drug abuse, physical signs of drug abuse, treatment
This PPT is based on Drug Addiction & Abuse..Anyone who is interested to download this ppt ,can comment on the comment section with their email id. I can assure you that I will send this original ppt to your email.
Drug & substance abuse Marijuana, Cocaine, Heroine, alcohol and prescription...OrnellaRN
Risk Factors, Effects on the brain,Symptoms, Warning signs and treatment.
Drugs and substances such as marijuana, cocaine and heroine are not the only substances that can be abused. Alcohol, prescription drugs and over-the-counter medications, inhalant and solvents, sedatives, coffee and cigarettes.
This is a drugs presentation for year 8 students who are learning about drugs and their effects of humans, this is being used as part of a PSHE course.
While club drugs are commonly considered a particular class of drug, the category actually encompasses several different types of drugs, all with their own unique risks, side effects, and concerns. These types include:
1. Hallucinogens
2. Dissociative Drugs
3. Methamphetamine
4.MDMA
Here, we break down each category of club drugs in more detail including common signs and symptoms, the potential effects and risks associated with each type of drug as well as their potential for addiction.
drug abuse- what is it? most common stimulants, cocaine abuse, aderall abuse, meth abuse, physiology of drug abuse, physical signs of drug abuse, treatment
This PPT is based on Drug Addiction & Abuse..Anyone who is interested to download this ppt ,can comment on the comment section with their email id. I can assure you that I will send this original ppt to your email.
Drug & substance abuse Marijuana, Cocaine, Heroine, alcohol and prescription...OrnellaRN
Risk Factors, Effects on the brain,Symptoms, Warning signs and treatment.
Drugs and substances such as marijuana, cocaine and heroine are not the only substances that can be abused. Alcohol, prescription drugs and over-the-counter medications, inhalant and solvents, sedatives, coffee and cigarettes.
This is a drugs presentation for year 8 students who are learning about drugs and their effects of humans, this is being used as part of a PSHE course.
While club drugs are commonly considered a particular class of drug, the category actually encompasses several different types of drugs, all with their own unique risks, side effects, and concerns. These types include:
1. Hallucinogens
2. Dissociative Drugs
3. Methamphetamine
4.MDMA
Here, we break down each category of club drugs in more detail including common signs and symptoms, the potential effects and risks associated with each type of drug as well as their potential for addiction.
Drug abuse is the excessive, maladaptive, or addictive use of drugs for nonmedical purposes which could create harmful effects on human health and society.
Purpose:
The purpose of this webinar is to raise awareness among the people about the demerits of such chemicals, their causes , their effects and preventive measures. The illegal use of drugs not only anguishes the persons mental and physical health but it destroys his family's life as well. The ignorance about the after effects of drugs could lead to destruction of society economically , ethically and health wise. Our collaborative movement towards this issue will help us eliminate the illegal usage of drugs. So , become a part of this movement by attending the session.
What is drug abuse ?
Physical & mental dependence,
Cause of drug abuse,
Route of administration,
Sign & symptoms of drug abuse,
How drug addiction occur,
Categories of drug abuse,
Various types of abused drug , their side effect & mechanism of action,
Prevention & control of drug abuse
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
2. Drug
A drug is something that affects your body.
Drugs must to pass through the body and
into the brain.
In pharmacology, a pharmaceutical
drugcalled a medication or medicine
It is a chemical substance used
to treat, cure, prevent, ordiagnose a disease
4. Legal drug
Laws and regulations control the availability,
quality and price of the 'legal' drugs; for
example, tobacco may not be sold to persons
under the age of 18.
5. Illegal drug
Because they are illegal, there are no price or
quality controls on the illicit drugs such as heroin
and ecstasy.
This means that a user can never be sure that
the drug they are taking is in fact what they think
it is; for example, PMA
(paramethoxyamphetamine), a toxic form of
amphetamine, has been sold as ecstasy.
The user also cannot be sure of a drug's strength
or purity.Various batches of an illegally
manufactured drug may have different mixtures
of the drug a
6. illegal drug
Possession: this includes physically carrying an illegal drug, or
having it at the person’s home or car etc. Possession also includes
jointly possessing a drug together with another person.
Supply or trafficking: this means providing a illegal drug to another
person.Traditionally a trafficker is considered someone who
exchanges drug(s) for money, property or services. However, if any
illegal drug is passed onto others (even friends) this is also
considered to be ‘trafficking’.
The penalties for drug offences vary depending on the age of the
offender (adult or minor), type of drug, quantities involved, previous
offences, and the state or territory in which the offence happened.
A criminal record can lead to difficulties getting a job, credit card
or even a visa for overseas travel.
Minor Drug Offence
Most states and territories will allow police to divert someone from
going to court if charged for a minor drug offence such as possession
of very small amounts of certain illegal drugs.
7. Major Drug Offence
If someone is caught with a larger quantity of
illegal drugs or is a repeat offender, they may not
qualify for a diversion or caution and could face
other penalties such as:
A fine
This can be up to $100,000.
A criminal penalty
This can include a heavy fine and/or
imprisonment which may be up to 25 years.
8.
9. Why is illegal drug use
dangerous ?
Damage to brain
Become addicted
Major factor in suicide, accidents and crimes
Risk of spreading disease through sharing
needle
Can result in overdose
Drug use leads to making irresponsible
decisions
11. Drugs classification
All drug ligal and illegal , classified into
different catagories based on similar effects
on mind and body
Depressants
Stimulants
Hallucinogens
Opiates
Designer drug
12. Depressants
Depressants are drugs that slow down the
functions of the central nervous system.
Depressant drugs do not necessarily make a
person feel depressed.
They include:
alcohol ('booze', 'grog') •
cannabis ('pot', 'dope', 'mull') •
barbiturates, including Seconal,Tuinal and
Amytal
• benzodiazepines (tranquilisers),Valium.
13. Stimulants
act on the central nervous system to speed up
the messages to and from the brain.
They can make the user feel more awake, alert
or confident.
Stimulants increase heart rate, body
temperature and blood pressure.
ephedrine used in medicines for bronchitis, hay
fever and asthma
• caffeine in coffee, tea and cola drinks
• nicotine in tobacco.
14. Hellucinogens
Hallucinogens affect perception.
People who have taken them may believe
they see or hear things that aren't really
there, or what they see may be distorted in
some way.
The effects of hallucinogens vary a great deal,
so it is impossible to predict how they will
affect a particular person at a particular time.
16. Cannabinoids
Marijuana (street names: Blunt, dope, ganja, grass, herb etc)
Hashish (street names: Boom, gangster, hash, hash oil, ,
etc)
Acute Effects: Euphoria; relaxation; slowed reaction time;
distorted sensory perception; impaired balance and
coordination; increased heart rate and appetite; impaired
learning, memory; anxiety; panic attacks; psychosis
Health Risks: Cough, frequent respiratory infections;
possible
mental health decline; addiction
17. Oppoids
Heroin (street names: Diacetylmorphine,smack,
horse, brown sugar, dope, etc)
Opium (street names: Laudanum, paregoric: big
O, black stuff, block, gum, hop, etc)
Acute Effects: Euphoria; drowsiness; impaired
coordination; dizziness; confusion; nausea;
sedation; feeling of heaviness in the body;
slowed or arrested breathing
Health Risks: Constipation; endocarditis;
hepatitis; HIV; addiction; fatal overdose
18. Club drug
These drugs are often used by young adults at all-night
dance parties, dance clubs and bars.They include:
MDMA (methylenedioxy-methamphetamine). Street
names: Ecstasy,Adam, clarity, etc.
Flunitrazepam (Street names: forget-me pill, Mexican
Valium, etc)
Ectasy,pcp
Acute Effects: for MDMA - Mild hallucinogenic effects;
empathic feelings; lowered inhibition; anxiety; chills;
sweating; teeth clenching; muscle cramping.
Sedation; muscle relaxation; confusion; memory loss;
dizziness; impaired coordination
For GHB - Drowsiness; nausea; headache; disorientation;
loss of coordination; memory loss
19. Dissociative Drugs
These include: Ketamine, PCP and analogs, Salvia
divinorum, Dextromethorphan (DXM)
Acute Effects: Feelings of being separate from one’s
body and environment; impaired motor function
For Ketamine - Analgesia; impaired memory;
delirium; respiratory depression and arrest; death
Analgesia; psychosis; aggression; violence; slurred
speech; loss of coordination; hallucinations
Euphoria; slurred speech; confusion; dizziness;
distorted visual perceptions
Health Risks: Anxiety; tremors; numbness; memory
loss; nausea
20. Inhalants
Drugs that are inhaled as vapours
The two most commomn inhalants used for
medical reasons are
Loughing gas, Asthma inhaler
Effects :
Hyperactivity
Loss of inhibition, dizzines, difficulty in
speaking etc
21. Marijuana
Is a word used to describe dried flowers,seed,and
leaves of indian hemp plant.
Effects;
Sensory distortion
Pank
Anxiety
Poor coordination of movement
Increase heartbeat
Long term : reduce resistance to common
illnesses,growth disorder, reduction of male sex
hormones.
22. Ectasy
Synthetic ,psychoactive drug that is
chemically similar to stimulants
Produce feelings of increase
energy,euphoria,emotional warmth
Commonly called rolling.